RAPT insider transaction filings
RAPT Therapeutics, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-03-05. Screen RAPT transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for RAPT between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — RAPT Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-05 | 4 | Kozick Linda — Director | Code (U): 4,956 · Disposition to issuer (D): 2,083 (derivative) · Disposition to issuer (D): 521 (derivative) · Disposition to issuer (D): 521 (derivative) · Disposition to issuer (D): 1,917 (derivative) · Disposition to issuer (D): 417 (derivative) · +6 more | EDGAR |
| 2026-03-05 | 4 | Giordano Michael F — Director | Code (U): 4,956 · Disposition to issuer (D): 824 (derivative) · Disposition to issuer (D): 799 (derivative) · Disposition to issuer (D): 938 (derivative) · Disposition to issuer (D): 938 (derivative) · Disposition to issuer (D): 402 (derivative) · +4 more | EDGAR |
| 2026-03-05 | 4 | Lyons-Williams Lori — Director | Code (U): 4,956 · Disposition to issuer (D): 2,813 (derivative) · Disposition to issuer (D): 1,063 (derivative) · Disposition to issuer (D): 1,618 (derivative) · Disposition to issuer (D): 4,561 (derivative) · Disposition to issuer (D): 32,229 (derivative) | EDGAR |
| 2026-03-05 | 4 | Wong Brian Russell — PRESIDENT AND CEO, Director | Code (U): 64,102 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 8,334 (derivative) · Disposition to issuer (D): 10,417 (derivative) · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 18,750 (derivative) · +5 more | EDGAR |
| 2026-03-05 | 4 | Braunstein Scott — Director | Code (U): 4,956 · Disposition to issuer (D): 25,000 (derivative) | EDGAR |
| 2026-03-05 | 4 | Brockstedt Dirk G. — CHIEF SCIENTIFIC OFFICER | Code (U): 4,648 · Disposition to issuer (D): 1,225 (derivative) · Disposition to issuer (D): 1,035 (derivative) · Disposition to issuer (D): 3,125 (derivative) · Disposition to issuer (D): 2,500 (derivative) · Disposition to issuer (D): 6,250 (derivative) · +5 more | EDGAR |
| 2026-03-05 | 4 | Young Rodney KB — CHIEF FINANCIAL OFFICER | Code (U): 3,304 · Disposition to issuer (D): 17,501 (derivative) · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 8,125 (derivative) · Disposition to issuer (D): 8,501 (derivative) · Disposition to issuer (D): 11,251 (derivative) · +2 more | EDGAR |
| 2026-03-05 | 4 | Dombkowski Ashley L. — Director | Code (U): 4,956 · Disposition to issuer (D): 25,000 (derivative) | EDGAR |
| 2026-03-05 | 4 | GRAY MARY ANN — Director | Code (U): 4,956 · Disposition to issuer (D): 2,813 (derivative) · Disposition to issuer (D): 498 (derivative) · Disposition to issuer (D): 938 (derivative) · Disposition to issuer (D): 478 (derivative) · Disposition to issuer (D): 938 (derivative) · +8 more | EDGAR |
| 2026-02-02 | 4 | Kozick Linda — Director | Grant/award (A): 4,956 @ $0 | EDGAR |
| 2026-02-02 | 4 | Giordano Michael F — Director | Grant/award (A): 4,956 @ $0 | EDGAR |
| 2026-02-02 | 4 | Lyons-Williams Lori — Director | Grant/award (A): 4,956 @ $0 | EDGAR |
| 2026-02-02 | 4 | Braunstein Scott — Director | Grant/award (A): 4,956 @ $0 | EDGAR |
| 2026-02-02 | 4 | Dombkowski Ashley L. — Director | Grant/award (A): 4,956 @ $0 | EDGAR |
| 2026-02-02 | 4 | GRAY MARY ANN — Director | Grant/award (A): 4,956 @ $0 | EDGAR |
| 2025-06-30 | 4 | Dombkowski Ashley L. — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | Wong Brian Russell — PRESIDENT AND CEO, Director | Grant/award (A): 637,500 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | Braunstein Scott — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | Brockstedt Dirk G. — CHIEF SCIENTIFIC OFFICER | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | HO WILLIAM — CHIEF MEDICAL OFFICER | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | Young Rodney KB — CHIEF FINANCIAL OFFICER | Grant/award (A): 118,750 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Giordano Michael F — Director | Grant/award (A): 257,832 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Lyons-Williams Lori — Director | Grant/award (A): 257,832 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Kozick Linda — Director | Grant/award (A): 257,832 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | GRAY MARY ANN — Director | Grant/award (A): 257,832 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Robbins Wendye — Director | Grant/award (A): 49,432 (derivative) @ $1.06 | EDGAR |
| 2025-04-02 | 4 | GRAY MARY ANN — Director | Grant/award (A): 61,202 (derivative) @ $1.06 | EDGAR |
| 2025-02-03 | 4 | Wong Brian Russell — PRESIDENT AND CEO, Director | Grant/award (A): 1,746,000 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | Brockstedt Dirk G. — CHIEF SCIENTIFIC OFFICER | Grant/award (A): 515,000 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | HO WILLIAM — CHIEF MEDICAL OFFICER | Grant/award (A): 450,000 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | Young Rodney KB — CHIEF FINANCIAL OFFICER | Grant/award (A): 642,000 (derivative) @ $0 | EDGAR |
| 2024-12-23 | 4 | COLUMN GROUP II, LP Column Group IV, LP — 10% owner Column Group IV-A, LP — 10% owner Column Group IV GP, LP — 10% owner TCG IV GP, LLC — 10% owner | Other (J): 1,352,008 · Other (J): 1,599,417 · Other (J): 1,352,008 (derivative) · Other (J): 1,599,417 (derivative) | EDGAR |
| 2024-12-23 | 4 | COLUMN GROUP II, LP Column Group II GP, LP — 10% owner PONOI CAPITAL, LP — 10% owner Ponoi Management, LLC — 10% owner Ponoi Capital II, LP — 10% owner Ponoi II Management, LLC — 10% owner Kutzkey Tim — 10% owner GOEDDEL DAVID V — 10% owner Svennilson Peter — 10% owner Column Group LLC — 10% owner | Other (J): 1,352,008 · Other (J): 1,599,417 · Other (J): 1,352,008 (derivative) · Other (J): 1,599,417 (derivative) | EDGAR |
| 2024-11-15 | 4 | Wong Brian Russell — PRESIDENT AND CEO, Director | Disposition to issuer (D): 83,333 (derivative) @ $0 · Grant/award (A): 83,333 (derivative) @ $0 · Disposition to issuer (D): 60,000 (derivative) @ $0 · Grant/award (A): 60,000 (derivative) @ $0 · Disposition to issuer (D): 150,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0 · +6 more | EDGAR |
| 2024-11-15 | 4 | Brockstedt Dirk G. — CHIEF SCIENTIFIC OFFICER | Disposition to issuer (D): 20,000 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0 · Disposition to issuer (D): 50,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 · Disposition to issuer (D): 55,000 (derivative) @ $0 · Grant/award (A): 55,000 (derivative) @ $0 · +4 more | EDGAR |
| 2024-11-15 | 4 | HO WILLIAM — CHIEF MEDICAL OFFICER | Disposition to issuer (D): 7,807 (derivative) @ $0 · Grant/award (A): 7,807 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0 · Disposition to issuer (D): 55,000 (derivative) @ $0 · Grant/award (A): 55,000 (derivative) @ $0 · +6 more | EDGAR |
| 2024-11-15 | 4 | Young Rodney KB — CHIEF FINANCIAL OFFICER | Disposition to issuer (D): 140,000 (derivative) @ $0 · Grant/award (A): 140,000 (derivative) @ $0 · Disposition to issuer (D): 60,000 (derivative) @ $0 · Grant/award (A): 60,000 (derivative) @ $0 · Disposition to issuer (D): 65,000 (derivative) @ $0 · Grant/award (A): 65,000 (derivative) @ $0 · +4 more | EDGAR |
| 2024-05-23 | 4 | Robbins Wendye — Director | Grant/award (A): 36,490 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | Lyons-Williams Lori — Director | Grant/award (A): 36,490 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | Kozick Linda — Director | Grant/award (A): 36,490 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | Giordano Michael F — Director | Grant/award (A): 36,490 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | GRAY MARY ANN — Director | Grant/award (A): 36,490 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | RIEFLIN WILLIAM JL — Director | Grant/award (A): 36,490 (derivative) @ $0 | EDGAR |
| 2024-04-01 | 4 | Robbins Wendye — Director | Grant/award (A): 6,925 (derivative) @ $7.58 | EDGAR |
| 2024-04-01 | 4 | GRAY MARY ANN — Director | Grant/award (A): 8,574 (derivative) @ $7.58 | EDGAR |
| 2024-04-01 | 4 | RIEFLIN WILLIAM JL — Director | Grant/award (A): 11,871 (derivative) @ $7.58 | EDGAR |
| 2024-02-01 | 4 | Wong Brian Russell — PRESIDENT AND CEO, Director | Grant/award (A): 275,000 (derivative) @ $0 | EDGAR |
| 2024-02-01 | 4 | Brockstedt Dirk G. — CHIEF SCIENTIFIC OFFICER | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-02-01 | 4 | HO WILLIAM — CHIEF MEDICAL OFFICER | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-02-01 | 4 | Young Rodney KB — CHIEF FINANCIAL OFFICER | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — RAPT Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-03-03 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-14 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-28 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-23 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-20 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-08 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=RAPT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →